Healthcare Providers and Services
Company Overview of 23andMe, Inc.
23andMe, Inc. operates as a personal genetics company that provides ancestry-related genetic reports and uninterpreted raw genetic data. The company helps individuals understand their own genetic information through DNA analysis technologies and Web-based interactive tools. Its Personal Genome Service enables individuals to gain deeper insights into their ancestry and inherited traits. The company was founded in 2006 and is based in Mountain View, California.
1390 Shorebird Way
Mountain View, CA 94043
Founded in 2006
Key Executives for 23andMe, Inc.
Chief Legal and Regulatory Officer
Vice President of Communications
Compensation as of Fiscal Year 2014.
23andMe, Inc. Key Developments
23andMe Appoints Ruby Gadelrab as Vice President, Commercial Marketing
Oct 20 14
23andMe announced the appointment of Ruby Gadelrab as vice president, commercial marketing. Gadelrab will oversee the global marketing efforts for the company's industry and academic collaborations. Before joining 23andMe, Gadelrab served as head of marketing and commercial development at Invitae Corporation. Prior to joining Invitae, Gadelrab worked at Affymetrix, Inc., where she most recently served as head of international marketing and clinical development.
23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease
Aug 12 14
23andMe, Inc. announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. The collaboration represents an innovative effort for both companies designed to explore the underlying genetics of IBD and it is hoped that the effort will ultimately lead to potential new or improved treatments for IBD. All study participants will receive 23andMe's Personal Genome Service(R) at no cost, including their ancestry analysis and uninterpreted raw genetic data. 23andMe will recruit individuals who are not current 23andMe customers and have also been diagnosed with Crohn's disease or ulcerative colitis by a qualified physician. Study participants will need to consent to provide a DNA sample (saliva), answer online surveys, and agree to share their data with researchers. The study is currently open to U.S. residents only.
23andMe Appoints Angela Wonson as VP of Communications
Jun 28 14
23andMe, Inc. announced that it has appointed Angela Wonson as vice president, communications. The company said that Wonson brings more than 18 years of communications experience in the health care, science and technology industries to 23andMe. She will oversee the company's corporate communications, media relations, investor relations and internal communications activities. Prior to joining 23andMe, Wonson served as vice president of communications and senior media advisor at Intuitive Surgical. Prior to joining Intuitive Surgical, Wonson held senior positions in health care media relations at both Weber Shandwick and Edelman Public Relations.
Similar Private Companies By Industry
Recent Private Companies Transactions
October 22, 2014
Most Searched Private Companies
Sponsored Financial Commentaries